NM_015450.3:c.1021C>A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_015450.3(POT1):c.1021C>A(p.Gln341Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000007 in 1,429,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015450.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POT1 | NM_015450.3 | c.1021C>A | p.Gln341Lys | missense_variant | Exon 13 of 19 | ENST00000357628.8 | NP_056265.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000457 AC: 1AN: 218770Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 119028
GnomAD4 exome AF: 7.00e-7 AC: 1AN: 1429444Hom.: 0 Cov.: 29 AF XY: 0.00000141 AC XY: 1AN XY: 711146
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tumor predisposition syndrome 3 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 341 of the POT1 protein (p.Gln341Lys). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POT1 protein function. This variant is present in population databases (rs767757297, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with POT1-related conditions. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.Q341K variant (also known as c.1021C>A), located in coding exon 9 of the POT1 gene, results from a C to A substitution at nucleotide position 1021. The glutamine at codon 341 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at